| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |